Dementia
Adams JD, Klaidman LK, Odunze IN, et al. Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide and vitamin E. Mol Chem Neuropathol 1991;14:213-26.
Allegro L et al. Oral phosphatidylserine in elderly patients with cognitive deterioration. An open study. Clin Trials J 1987; 24:104-8.
Barabas J et al. Ascorbic acid in cerebrospinal flud - a possible protection against free radicals in the brain. Arch Gerontol Geriatr 1995; 21:43-8.
Behl C, Davis J, Cole G, et al. Vitamin E protects nerve cells from amyloid B protein toxicity. Biochem Biophys Res Commun 1992;186(2):944-50.
Bell IR et al. Vitamin B12 and folate status in acute geropsychiatric patients: Affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatry 1990; 27:125-37.
Beta-carotene said to protect against cognitive impairment. Medical Tribune September 5, 1996:17.
Bohnen N, Jolles J, Degenaar CP. Lower blood levels of vitamin B-12 are related to decreased performance of healthy subjects in the Stroop Color-Word Test. Neurosci Res Commun 1992; 11:53-6.
Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int J Clin Pharmacol Ther Toxicol 1986; 24:511-16.
Bottiglieri T, Godfrey P, Flynn T, et al. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990; 53(12):1096-8.
Brewer GJ et al. Oral zinc therapy for Wilson's disease. Ann Intern Med 99:314-20, 1983.
Brinkman SD et al. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease). Brief Reports 1982;2:281-5.
Caffarra P, Santamaria V. The effects of phosphatidylserine in patients with mild cognitive decline. An open trial. Clin Trials J 1987; 24:109-14.
Cipolli C, Chiari G. Effects of L-acetylcarnitine on mental deterioration in the aged: initial results. Clin Ter 132:479-510, 1990.
Clausen J et al. Biochemical and clinical effects of an antioxidative supplementation of geriatric patients. Biol Trace Element Res 20:135-51, 1989.
Collin P, Pirttila T, Nurmikko T, et al. Coeliac disease, brain atrophy and dementia. Neurology 41:372-5, 1991.
Corrigan FM, Van Rhijn AG, Ijomah G, et al. Tin and fatty acids in dementia. Prostaglandins Leukot Essent Fatty Acids 1991;43(4):229-38.
Crook TH, Tinklenberg J, Yesavage J, et al. Effects of phosphatidylserine in age-associated memory impairment. Neurology 1991; 41:644-9.
Deijen JB, van der Beek EJ, Orlebeke JF, van den Berg H. Vitamin B6 supplementation in elderly men. Effects on mood,memory, performance, and mental effort. Psychopharmacology 109:489-96, 1992.
Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, Ylieff M. Double-blind randomized controlled study of phosphatidylserine in senile demented patients. Acta Neurol Scand 73:136-40, 1986.
Di Trapani G et al. Dementia-peripheral neuropathy during combined deficiency of vitamin B12 and folate. Light microscopy and ultrastructural study of sural nerve. Ital J Neurol Sci 7(5):545-52, 1986.
Enk C et al. Reversible dementia and neuropathy associated with folate deficiency 16 years after partial gastrectomy. Scand J Haematol 25(1):63-6, 1980.
Ferrier IN, Leake A, Taylor GA, et al. Reduced gastrointestinal absorption of calcium in dementia. Age Ageing 19(6):368-75, 1990.
Forbes WF, Hayward LM, Agwani N. Dementia, aluminium, and fluoride. Lttr Lancet 338:1592-3, 1991.
Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ 312:608-11, 1996.
Garruto RM et al. Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 35(2):193-8, 1985.
Garzya G, Corallo D, Flore A, et al. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression. Drugs Exp Clin Res 16:101-6, 1990.
Gindin J et al. The effect of plant phosphatidylserine on age-associated memory impairment and mood in the functioning elderly. Rehovot, Israel. Geriatric Institute for Education and Research and Dept. of Geriatrics, Kaplan Hospital, 1995.
Gold M, Chen MF, Johnson K. Plasma and red blood cell thiamine deficiency in patients with dementia of the Alzheimer's type. Arch Neurol 52(11):1081-6, 1995.
Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 249:2917-21, 1983.
Granata Q, DeMichele J. Phosphatidylserine in elderly patients. An open trial. Clin Trials J 24:99-103, 1987.
Grodstein F, Chen J, Willett WC. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr. 2003 Apr;77(4):975-84.
Gronek I, Kolomaznik M. Serum zinc levels in various mental disorders. Zh Nevropatol Psikhiatr 90(10):126-7, 1989.
Guarnaschelli C, Fugazza G, Pistarine C. Pathological brain ageing: evaluation of the efficacy of a pharmacological aid. Drugs Exp Clin Res 14:715-18, 1988.
Holmes JM. Cerebral manifestations of vitamin B12 deficiency. Br Med J ii:1394-8, 1956.
Howard JMH. Clinical import of small increases in serum aluminum. Clin Chem 30(10):1722-3, 1984.
Hullin RP. Serum zinc in psychiatric patients. Prog Clin Biol Res 129:197-206, 1983.
Inada M et al. Cobalamin contents of the brains in some critical and pathologic states. Int J Vitam Nutr Res 52(4):423-9, 1982.
Jacqmin-Gadda H, Commenges D, Letenneur L, et al. Silica and aluminum in drinking water and cognitive impairment in the elderly. Epidemiology 7(3):281-5, 1996.
John R Feussner, Durham VA Medical Center and Duke U. School of Medicine - presentation to the Southern Section of the Society for Research and Education in Primary Care Internal Medicine, USA, 1984.
Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 145(1):33-41, 1997.
Kanof P. Red blood cell choline. Biol Psychiatry 20:375-83, 1985.
Karnaze DS, Carmel R. Low serum cobalamin levels in primary degenerative dementia. Do some patients harbor atypical cobalamin deficiency states? Arch Intern ed 147(3):429-31, 1987.
Karnaze DS, Carmel R. Neurologic and evoked potential abnormalities in subtle cobalamin deficiency states, including deficiency without anemia and with normal absorption of free cobalamin. Arch Neurol 47(9):1008-12, 1990.
Lammi UK et al. Mental disability among elderly men in Finland: prevalence, predictors and correlates. Acta Psychiatr Scand 80(5):459-68, 1989.
Lehmann J et al. Tryptophan malabsorption in dementia. Improvement in certain cases after tryptophan therapy as indicated by mental behaviour and blood analysis. Acta Psychiatr Scand 64(2):123-31, 1981.
Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 318(26):1720-8, 1988.
Lombardi GF. Pharmacological treatment with phosphatidyl serine of 40 ambulatory patients with senile dementia syndrome. Minerva Med 80:599-602, 1989.
McLachlan DR et al. Aluminum and neurodegenerative disease: Therapeutic implications. Am J Kidney Dis 6(5):322-9, 1985.
Maggioni M et al. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr Scand 81:265-70, 1990.
Martin DC. B12 and folate deficiency dementia. Clin Geriatr Med 4(4):841-52, 1988; Strachan RW, Henderson JG. Dementia and folate deficiency. Quart J Med 36:189-204, 1967.
MartinDC et al. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 40(2):168-72, 1992.
Mastrogiacomo F et al. Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease. Ann Neurol 39:585-91, 1996.
Meador KJ, Nichols ME, Franke P, et al. Evidence for a central cholinergic effect of high-dose thiamine. Ann Neurol 34(5):724-6, 1993.
Ogihara T, Miya K, Morimoto S. Possible participation of calcium-regulating factors in senile dementia in elderly female subjects. Gerontology 36 Suppl 1:25-30, 1990.
Ortega RM, Manas LR, Andres P, et al. Functional and psychic deterioration in elderly people may be aggravated by folate deficiency. J Nutr 126:1992-9, 1996.
Palmieri G et al. Double-blind controlled trial of phosphatidylserine in patients with senile mental deterioration. Clin Trials J 24:73-83, 1987.
Perl DP et al. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 217:1053-5, 1982.
Passeri M, Chcinotta D, Bonati PA, et al. Acetyl-L-carnitine in the treatment of mildly demented elderly patients. Int J Clin Pharmacol Res 10(1-2):75-9, 1990.
Pavlova GA. Content of amino acids, ionized forms of calcium and acetylcholinesterase in the cerebral cortex in senile dementia. Zh Nev Pshtr 84(7):1012-6, 1984.
Puca FM et al. Exploratory trial of phosphatidylserine efficacy in mildly demented subjects. Clin Trials J 24:94-8, 1987.
Ransmayr G et al. Double-blind placebo-controlled trial of phosphatidylserine in elderly patients with arteriosclerotic encephalopathy. Clin Trials J 24:62-72, 1987.
Regland B, Gottfries CG, Oreland L. Vitamin B12-induced reduction of platelet monamine oxidase activity in patients with dementia and pernicious anemia. Eur Arch Psychiatry Clin Neurosci 240(4-5): 288-91, 1991.
Repasy A et al. Utility of routine vitamin B12 levels in the workup of dementia. Abstract. Psychogeriatrics pp. 32-3, Dec. 1987.
Riggs KM, Sprio A III, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 63:306-14, 1996.
Salvioli G, Neri M. L-acetylcarnitine treatment of mental decline in the elderly. Drugs Exp Clin Res 20(4):169-76, 1994.
Schorah CJ et al. Plasma vitamin C concentrations in patients in a psychiatric hospital. Hum Nutr Clin Nutr 37C:447-52, 1983.
Schurr A et al. Glutamine protects neuronal function against cerebral hypoxia: A study using the in vitro hippocampal slice preparation. Brain Res 412(1):179-81, 1987.
Schurr A et al. Taurine improves the recovery of neuronal function following cerebral hypoxia: An in vitro study. Life Sci 40(21):2059- 66, 1987.
Shaw DM, Tidmarsh SF, Sweeney EA, et al. Pilot study of amino acids in senile dementia. Br J Psychiatry 139:580, 1981.
Simonoff M et al. Serum and erythrocyte selenium in normal and pathological states in France. Trace Elem Med 5:64-9, 1988.
Sinforiani E, Iannuccelli M, Mauri M, et al. Neuropsychological changes in demented patients treated with acetyl-L- carnitine. Int J Clin Pharmacol Res 10(1-2):69-74, 1990.
Sommer BR, Wolkowitz OM. RBC folic acid levels and cognitive performance in elderly patients: a preliminary report. Biol Psychiatry 24:352-4, 1988.
Spivak JL, Jackson DL. Pellagra: an analysis of 18 patients and a review of the literature. Johns Hopkins Med J 140(6):295-309, 1977.
Thomas DE et al. Tryptophan and nutritional status of patients with senile dementia. Psychol Med 16(2):297-305, 1986.
Torizumi K et al. Relationship between parathyroid hormone and magnesium in sera of dementia patients. Radioisotopes 37(4):203-8, 1988.
Tully CL et al. Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun Study. NeuroReport 6:2105-8, 1995.
Villardita C et al. Multicentre clinical trial of brain phosphatidylserine in elderly patients with intellectual deterioration. Clin Trials J 24:84-93, 1987.
Ward NI, Mason JA. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J Radioanalyt Nucl Chem 113(2):515-26, 1987.
Warsama JJ, Launer LJ, Witterman JEM, et al. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam study. Am J Epidemiol 144:275-9, 1996.
Watkins SE et al. Plasma amino acids in patients with senile dementia and in subjects with Down's syndrome at an age vulnerable to Alzheimer changes. J Ment Defic Res 1989; 33:159-66.
Wilson SA. Progressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liver. Brain 1912; 34:295-507.
Yanagihara R et al. Calcium and vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis and parkinsonism-dementia. Ann Neurol 1984; 15(1):42-8.
